THRD — THIRD HARMONIC BIO INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 3 家机构在其最新 13F 申报中持有 THRD(THIRD HARMONIC BIO INC),合计申报市值 $109.99K,对应 20.44K 股。按股数计算较上季度增持 0.0%(+0 股),申报市值环比上升 0.0%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。
与上一季度相比,1 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
THIRD HARMONIC BIO INC(THRD)的主要机构持有人包括 Atlas Venture Life Science Advisors, LLC、GENERAL ATLANTIC, L.P.、EcoR1 Capital, LLC,按 13F 申报市值在本页 180 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 2 | 20.44K | $109.95K | +0.0% |
| Q2 2026 | 3 | 20.44K | $109.99K | +0.0% |
| Q1 2026 | 4 | 20.46K | $109.99K | -1.4% |
| Q4 2025 | 4 | 20.75K | $111.54K | -2.1% |
| Q3 2025 | 13 | 499.95K | $1.19M | -6.9% |
| Q2 2025 | 111 | 40.17M | $218.06M | +7.0% |
| Q1 2025 | 100 | 39.33M | $136.46M | +5.1% |
| Q4 2024 | 100 | 46.04M | $470.00M | +1.0% |
表内 8 个季度中,机构持股合计减少 100%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+7.0%)。
前 25 大机构持仓人(Q3 2026) — 2 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.98K | $107.49K | 0.00% | 持有 | |
| 458 | $2.46K | 0.00% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 3 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.98K | $107.49K | 0.00% | 持有 | |
| 458 | $2.46K | 0.00% | 持有 | |
| 1 | $41 | 0.00% | 持有 |
Q1 2026 — 4 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.98K | $107.49K | 0.00% | 减持 | |
| 458 | $2.46K | 0.00% | 持有 | |
| 1 | $41 | 0.00% | 持有 | |
| 20 | $1 | 0.00% | 持有 |
Q4 2025 — 4 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 20.27K | $109.03K | 0.00% | 减持 | |
| 458 | $2.46K | 0.00% | 持有 | |
| 1 | $41 | 0.00% | 持有 | |
| 20 | $1 | 0.00% | 持有 |
Q3 2025 — 13 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 93.94K | $505.39K | 0.00% | 持有 | |
| 86.33K | $464.43K | 0.01% | 新进 | |
| 20.71K | $111.40K | 0.00% | 减持 | |
| 16.86K | $90.70K | 0.00% | 持有 | |
| 250.00K | $7.50K | 0.00% | 新进 | |
| 803 | $4.32K | 0.00% | 增持 | |
| 665 | $4.00K | 0.00% | 持有 | |
| 458 | $2.46K | 0.00% | 增持 | |
| 196 | $1.05K | 0.00% | 新进 | |
| 27.96K | $839 | 0.00% | 持有 | |
| 2.02K | $61 | 0.00% | 持有 | |
| 1 | $41 | 0.00% | 持有 | |
| 20 | $1 | 0.00% | 持有 |
Q2 2025 — 25 家基金
新建仓(Q2 2026)
本季度没有基金新建该仓位。
完全清仓(较上季)
- SBI Securities Co., Ltd. 卖出 20 股 · $1
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 19.98K | 19.98K | 19.98K | 20.27K | 20.71K | 33.67K | 28.17K | 28.92K | 28.72K | 28.60K | 20.66K | 19.77K | 18.63K | — | — | — | — |
| GAMMA Investing LLC | 458 | 458 | 458 | 458 | 458 | 105 | — | 97 | 120 | 113 | 97 | 77 | — | — | — | — | — |
| Atlas Venture Life Science Advisors, LLC | — | — | — | — | — | 10.40M | 10.40M | 10.40M | 10.91M | 10.91M | 10.91M | 10.91M | 10.91M | — | — | — | — |
| ORBIMED ADVISORS LLC | — | — | — | — | — | 5.78M | 5.78M | 5.78M | 5.78M | 5.78M | 5.78M | 5.78M | 5.78M | — | — | — | — |
| BVF INC/IL | — | — | — | — | — | — | 2.37M | 2.37M | 4.37M | 4.37M | 4.37M | 4.37M | 4.37M | — | — | — | — |
| EcoR1 Capital, LLC | — | — | — | — | — | — | — | 3.18M | 3.18M | 3.18M | 3.18M | 3.18M | 2.98M | — | — | — | — |
| GENERAL ATLANTIC, L.P. | — | — | — | — | — | — | — | 3.37M | 2.96M | 2.96M | 2.96M | 2.96M | 2.96M | — | — | — | — |
| T. Rowe Price Investment Management, Inc. | — | — | — | — | — | — | — | 2.93M | 2.83M | 1.35M | — | — | — | — | — | — | — |
| TCG Crossover Management, LLC | — | — | — | — | — | 1.92M | 2.51M | 2.51M | 2.42M | — | — | — | — | — | — | — | — |
| RA CAPITAL MANAGEMENT, L.P. | — | — | — | — | — | — | — | 960.62K | 1.28M | 2.03M | 2.03M | 2.03M | 961.86K | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | 4.41K | 1.07K | 2.54M | 307.99K | 3.74K | 3.77K | 3.72K | 3.44K | 2.75K | 981 | 109 | — |
| BML Capital Management, LLC | — | — | — | — | — | 3.82M | 3.82M | — | — | — | — | — | — | — | — | — | — |
| Boxer Capital Management, LLC | — | — | — | — | — | — | — | 2.00M | — | — | — | — | — | — | — | — | — |
| Commodore Capital LP | — | — | — | — | — | — | — | 237.70K | 1.36M | 1.55M | 1.25M | 706.71K | 1.70M | — | — | — | — |
| BlackRock Inc | — | — | — | — | — | 1.73M | 1.48M | 1.48M | 1.46M | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | — | — | — | — | — | 2.94M | 2.94M | 501.00K | — | — | — | — | — | — | — | — | — |
| BRAIDWELL LP | — | — | — | — | — | — | — | — | — | — | — | 1.32M | 1.65M | — | — | — | — |
| Vanguard Group | — | — | — | — | — | 1.30M | 1.16M | 1.03M | 891.65K | 873.80K | 851.39K | 839.88K | 773.46K | 769.84K | 747.95K | 696.37K | 100.00K |
| TANG CAPITAL MANAGEMENT LLC | — | — | — | — | — | 929.73K | 929.73K | 150.00K | — | — | — | — | 1.80M | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | 95.54K | 264.42K | 36.15K | 13.41K | 13.44K | 442.14K | 1.01M | 12.96K | 15.52K | 61 | 18.88K | — |
常见问题
Which funds hold THRD?
As of 2026-Q2, 3 institutional funds reported holding THRD (THIRD HARMONIC BIO INC) in SEC 13F filings, with a combined reported value of $109.99K.
How many shares of THRD do institutions own?
13F filers reported 20.44K shares of THRD, worth $109.99K in aggregate at the end of 2026-Q2.
Is institutional ownership of THRD rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of THRD?
The largest 13F holders are Atlas Venture Life Science Advisors, LLC, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, T. Rowe Price Investment Management, Inc.; the top 25 are ranked at the top of this page.
Who are the major shareholders of THIRD HARMONIC BIO INC?
The major shareholders of THIRD HARMONIC BIO INC (THRD) by reported 13F value are Atlas Venture Life Science Advisors, LLC, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, T. Rowe Price Investment Management, Inc., among 180 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.